1. Introduction
===============

Marine fungi are known to be a prolific source of biologically active natural products which might be useful for drug discovery \[[@B1-marinedrugs-11-02230],[@B2-marinedrugs-11-02230]\]. As a special ecosystem, marine sediment provides an abundant of fungal resources, which yielded various secondary metabolites with novel structures and interesting biological activities \[[@B3-marinedrugs-11-02230],[@B4-marinedrugs-11-02230],[@B5-marinedrugs-11-02230]\]. In the course of our search for bioactive metabolites from marine-derived fungi \[[@B6-marinedrugs-11-02230],[@B7-marinedrugs-11-02230],[@B8-marinedrugs-11-02230],[@B9-marinedrugs-11-02230],[@B10-marinedrugs-11-02230],[@B11-marinedrugs-11-02230]\], a strain of *Penicillium pinophilum* SD-272, which was isolated from sediment samples collected from the estuary of the Pearl River in South China Sea, attracted our attention. The EtOAc extract of the culture extract yielded a new diketopiperazine derivative, pinodiketopiperazine A (**1**), a new phthalide derivative, 6,7-dihydroxy-3-methoxy-3-methylphthalide (**2**), as well as alternariol 2,4-dimethyl ether (**3**) \[[@B12-marinedrugs-11-02230],[@B13-marinedrugs-11-02230]\] and [l]{.smallcaps}-5-oxoproline methyl ester (**4**) \[[@B14-marinedrugs-11-02230]\], which were isolated from a natural source for the first time but have been previously synthesized ([Figure 1](#marinedrugs-11-02230-f001){ref-type="fig"}). In addition, six known compounds (**5**--**10**) were also isolated and identified. We present herein the isolation, structural elucidation, absolute configuration determination, and biological activity of these compounds.

![Structures of the isolated compounds **1**--**10** and the reference compound **11**.](marinedrugs-11-02230-g001){#marinedrugs-11-02230-f001}

2. Results and Discussion
=========================

2.1. Structure Elucidation of the New Compounds
-----------------------------------------------

Compound **1** was obtained as yellowish oil and HRESIMS data established its molecular formula as C~15~H~18~N~2~O~3~, indicating eight degrees of unsaturation. In the ^1^H NMR spectrum ([Table 1](#marinedrugs-11-02230-t001){ref-type="table"}), signals for a mono-substituted phenyl group (H-2′--H-6′) and a tri-substituted double bond (H-10) were presented, as well as a nitrogenated or oxygenated methine (H-3), three methylenes (H-7--H-9), and a tertiary methyl (H-11) group. The ^13^C and DEPT NMR spectroscopic data ([Table 1](#marinedrugs-11-02230-t001){ref-type="table"}) exhibited the presence of 15 carbon signals which were further classified into one methyl, three methylenes (with one oxygenated), seven methines, and four quaternary (with two amide ester carbonyl and two olefinic quaternary) carbon atoms. The ^1^H--^1^H COSY spectrum ([Figure 2](#marinedrugs-11-02230-f002){ref-type="fig"}) revealed two spin systems corresponding to two substructures, with the first one being a phenyl group which connected to the double bond as evidenced by the HMBC correlation from H-10 to C-2′/C-6′ ([Figure 2](#marinedrugs-11-02230-f002){ref-type="fig"}). The second substructure being started from an exchangeable NH proton (NH-2), followed by a methine proton H-3, which connected to a straight chain consisting of three methylene groups (CH~2~-7--CH~2~-9) and terminated with an OH group ([Figure 2](#marinedrugs-11-02230-f002){ref-type="fig"}). The connection of the above substructures in **1** as mentioned above was established by detailed inspection of the key HMBC correlations from H-10 to C-1, from H~3~-11 to C-4 and C-6, and from NH-2 to C-4 and C-6. The structure of compound **1** was therefore elucidated as shown in [Figure 1](#marinedrugs-11-02230-f001){ref-type="fig"}. A trivial name pinodiketopiperazine A was assigned to this compound.

![Key COSY (bold lines) and HMBC (arrows) correlations for compounds **1** and **2**.](marinedrugs-11-02230-g002){#marinedrugs-11-02230-f002}
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###### 

^1^H- and ^13^C-NMR data of compound **1** in DMSO-*d*~6~^a^.

  No.    δ~C~          δ~H~ ( *J* in Hz)   No.     δ~C~          δ~H~ ( *J* in Hz)
  ------ ------------- ------------------- ------- ------------- -------------------
  1      162.5, C                          9       60.1, CH~2~   3.40, m
  2-NH                 8.62, d (2.8)       10      118.1, CH     6.97, s
  3      55.0, CH      3.94, m             11      34.5, CH~3~   2.73, s
  4      167.9, C                          1′      133.8, C      
  6      132.4, C                          2′/6′   129.2, CH     7.42, d (7.5)
  7      30.6, CH~2~   a 1.79, m           3′/5′   128.3, CH     7.30, t (7.5)
                       b 1.71, m           4′      128.1, CH     7.34, t (7.5)
  8      28.0, CH~2~   1.51, m             OH                    4.48, br s

^a^ Measured at 500 MHz for ^1^H and 125 MHz for ^13^C.

To determine the absolute configuration of **1**, the electronic circular dichroism (ECD) was experimentally recorded and it showed negative Cotton effects at 203 and 288 nm ([Figure 3](#marinedrugs-11-02230-f003){ref-type="fig"}). The theoretical ECD was then calculated using the time-dependent DFT (density function theory) method at the B3LYP/6-31G(d) level and was compared with that of the experimental data. The side chain at C-3 in **1** was truncated to a methyl (**1a** and **1b**) ([Figure 4](#marinedrugs-11-02230-f004){ref-type="fig"}) since it contributes little to the ECD spectrum \[[@B15-marinedrugs-11-02230],[@B16-marinedrugs-11-02230]\]. The results showed that, although a slightly peaked shift was observed, the calculated curve of **1a** (with 3*R*-configuration) was in good agreement with that of the experimental one ([Figure 3](#marinedrugs-11-02230-f003){ref-type="fig"}), which indicated that the absolute configuration at C-3 of **1** was *R*.

![Experimental and calculated electronic circular dichroism (ECD) spectra of **1a** (3*R*) and **1b** (3*S*).](marinedrugs-11-02230-g003){#marinedrugs-11-02230-f003}

![Model compounds **1a** and **1b** for ECD calculations.](marinedrugs-11-02230-g004){#marinedrugs-11-02230-f004}

Compound **2** was obtained as white amorphous powder and its molecular formula C~10~H~10~O~5~ was determined on the basis of the positive HRESIMS. Detailed analysis of the NMR spectroscopic data ([Table 2](#marinedrugs-11-02230-t002){ref-type="table"}) revealed that the structure of **2** was similar to (*S*)-3-ethyl-7-hydroxy-6-methoxyphthalide (**11**, [Figure 1](#marinedrugs-11-02230-f001){ref-type="fig"}) \[[@B17-marinedrugs-11-02230]\]. However, the C-6 OMe group in **11** was replaced by OH group in **2** as evidenced by the fact that the resonances corresponding to the C-6 OMe group at δ~H~ 3.84/δ~C~ 56.2 in the NMR spectra of **11** disappeared in that of **2**. In addition, the proton signals at δ~H~ 5.51 (H-3), 1.83/2.30 (H-8), and 0.95 (H-9) as well as the carbon signals at δ~C~ 83.3 (CH, C-3), 25.9 (CH~2~, C-8), and 9.1 (CH~3~, C-9) in the NMR spectra of **11** were missing in that of **2**. Instead, signals resonating at δ~C~ 108.6 (C) for a ketal carbon (C-3), at δ~H~ 1.74/δ~C~ 25.6 for a methyl group (CH~3~-8), and at δ~H~ 2.94/δ~C~ 52.4 for an OMe group (OCH~3~-9), were observed in the NMR spectra of **2** ([Table 2](#marinedrugs-11-02230-t002){ref-type="table"}). The HMBC correlations from H-8 and H-9 to C-3 and from H-8 to C-3a supported the above deduction ([Figure 2](#marinedrugs-11-02230-f002){ref-type="fig"}). The structure of **2** was thus determined as 6,7-dihydroxy-3-methoxy-3-methylphthalide. To unambiguously determine the absolute configuration, compound **2** was also submitted to ECD measurement and calculation. However, no obvious Cotton effect was observed in the experiment. Thus, ECD was not applicable to resolve the absolute configuration of compound **2**. By comparison of its optical rotation (\[α\]~D~^27^ −8.3, *c* 0.12, CHCl~3~) with that of the (*S*)-3-ethyl-7-hydroxy-6-methoxyphthalide (**11**) (\[α\]~D~^25^ −71.5, *c* 0.10, CHCl~3~) \[[@B17-marinedrugs-11-02230]\], the *S-*configuration at C-3 was tentatively deduced to this compound.
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###### 

^1^H- and ^13^C-NMR data of compound **2** in DMSO-*d*~6~^a^.

  No.   δ~C~        δ~H~ ( *J* in Hz)   No.   δ~C~          δ~H~ ( *J* in Hz)
  ----- ----------- ------------------- ----- ------------- -------------------
  1     167.6, C                        6     146.6, C      
  3     108.6, C                        7     151.1, C      
  3a    132.9, C                        7a    114.6, C      
  4     121.2, CH   6.84, d (8.5)       8     25.6, CH~3~   1.74, s
  5     125.7, CH   7.01, d (8.5)       9     52.4, CH~3~   2.94, s

^a^ Measured at 500 MHz for ^1^H and 125 MHz for ^13^C.

Compounds **3** and **4** were previously reported as synthetic products and were obtained and described here for the first time as naturally occurring fungal metabolites \[[@B12-marinedrugs-11-02230],[@B13-marinedrugs-11-02230],[@B14-marinedrugs-11-02230]\]. The NMR data for compound **3** was not published previously and the fully assigned ^1^H and ^13^C NMR data for this compound were provided in the [Experimental Section](#sec3-marinedrugs-11-02230){ref-type="sec"}.

In addition to compounds **1**--**4**, six known secondary metabolites including *N*-methylphenyldehydroalanyl-[l]{.smallcaps}-prolin-anhydrid (**5**) \[[@B18-marinedrugs-11-02230],[@B19-marinedrugs-11-02230]\], cyclo-*trans*-4-OH-([d]{.smallcaps})-Pro-([d]{.smallcaps})-Phe (**6**) \[[@B20-marinedrugs-11-02230]\], cyclo([d]{.smallcaps})-Pro-([d]{.smallcaps})-Val (**7**) \[[@B20-marinedrugs-11-02230]\], rubralide C (**8**) \[[@B21-marinedrugs-11-02230]\], 5′-epialtenuene (**9**) \[[@B22-marinedrugs-11-02230]\] and altenuene (**10**) \[[@B22-marinedrugs-11-02230]\] ([Figure 1](#marinedrugs-11-02230-f001){ref-type="fig"}), were also isolated, and their structures were elucidated by comparing the NMR data with those of literature reports \[[@B18-marinedrugs-11-02230],[@B19-marinedrugs-11-02230],[@B20-marinedrugs-11-02230],[@B21-marinedrugs-11-02230],[@B22-marinedrugs-11-02230]\].

2.2. Biological Activities of the Isolated Compounds
----------------------------------------------------

The isolated compounds **1**--**10** were evaluated for the brine shrimp (*Artemia salina*) lethal activity and antibacterial activity. Among them, compound **2** was found to possess potent lethality with LD~50~ 11.2 μM, which is more active than that of the positive control colchicine (with LD~50~ 92.1 μM), but the other tested compounds only displayed weak activity. In the antibacterial assay, compounds **1**, **3**, **5**--**8**, and positive control chloromycetin displayed inhibitory activity against *Escherichia coli*, causing the 10.0, 9.0, 8.0, 8.0, 7.0, 10.0, and 15.0 mm zones of inhibition at 20 μg/disk, respectively.

3. Experimental Section {#sec3-marinedrugs-11-02230}
=======================

3.1. General
------------

NMR Spectra was recorded on a Bruker Avance-500 MHz spectrometer (500 MHz for ^1^H and 125 MHz for ^13^C) and chemical shifts were recorded as δ values. Low and high ESI-Mass spectra were performed on a VG Auto spec 3000 spectrometer. Optical rotations were obtained on Optical Activity A-55 polarimeter. UV Spectra were measured in methanol on a Lengguang Gold S54 spectrophotometer. Silica gel (SiO~2~; 100--200 mesh, 200--300 mesh and GF~254~) for column chromatography and preparative thin-layer chromatography were produced by Qingdao Haiyang Chemical Group Corporation. RP-18 reverse-phase silica gel (40--63 µm) and Sephadex LH-20 were purchased from the Merck Corporation. All solvents were distilled to use.

3.2. Fungal Material
--------------------

The fungal strain *Penicillium pinophilum* SD-272 was isolated from the sediment sample collected from the estuary of the Pearl River in South China Sea, in October 2010. The fungal identification was achieved by analysis of the ITS region of its rDNA as described previously \[[@B23-marinedrugs-11-02230]\]. The sequence data obtained from the fungus has been submitted to GeneBank with accession number KC 427134. A voucher specimen was stored at the Key Laboratory of Experimental Marine Biology of the Institute of Oceanology, Chinese Academy of Sciences.

3.3. Fermentation
-----------------

One hundred 1000-mL Erlenmeyer flasks, each contains 300 mL liquid medium (sucrose 2%, peptone 0.5%, yeast extract 0.3%, monosodium glutamate 1%, mannitol 2%, potato flour 0.4%, seawater, pH 6.5), were sterilized at 116 °C for 20 min and cooled to room temperature subsequently. A piece of mycelium (size 3 cm^2^) growing on malt agar plate was inoculated into 1000-mL Erlenmeyer flask. Static fermentation was then conducted at 28 °C for 35 days.

3.4. Extraction and Isolation
-----------------------------

The culture broth was filtrated using filter paper and separated into mycelia and culture broth. The air-dried mycelia were immersed in acetone-H~2~O (4:1) with ultrasonic processor for 20 min and then extracted three times with ethyl acetate, while the culture broth was stirred for three times with ethyl acetate and then concentrated to obtain an organic extract. Since the two extract show similar HPLC and TLC profiles, they were combined to afford a crude extract (50.2 g) for further purification.

The crude extract was subjected to vacuum liquid chromatography (VLC) on silica gel eluting with step solvents of increasing polarity (from petroleum ether to MeOH) to yield 9 fractions (Fr.1--Fr.9). Fr.1 was subjected to Sephadex LH-20 (acetone) and preparative-TLC to afford **2** (4.5 mg). Fr.3 was separated by column chromatography (CC) on Lobar LiChroprep C~18~ eluting with MeOH--H~2~O gradient to give five sub-fractions (Fr.3.1--Fr.3.5). Fr.3.3 was then chromatographed on silica gel eluting with CHCl~3~--MeOH gradient (60:1) and further purified by Sephadex LH-20 (MeOH) to afford **3** (9.4 mg), **5** (7.1 mg), and **8** (5.1 mg). Fr.4 was also further separated by CC on silica gel to give five subfractions (Fr.4.1--Fr.4.5). Fr.4.2 was purified by CC on Sephadex LH-20 (MeOH) and by semi-preparative HPLC using MeOH--H~2~O gradient (50:50) to yield **1** (4.1 mg, *t~R~* 25.6 min), **7** (7.0 mg, *t~R~* 18.1 min), and **6** (28.7 mg, *t~R~* 20.8 min). Fr.4.4 was subjected to CC on silica gel using CHCl~3~--MeOH gradient (50:1) and purified by Sephadex LH-20 (acetone) to get **9** (10.2 mg), **10** (5.4 mg), and **4** (14.6 mg).

Compound **1**: yellowish oil; \[α\]~D~^27^ −224 (*c* 0.25, MeOH); UV (MeOH) λ~max~ (log ε) 200 (4.31), 291 (4.09) nm; CD λ~max~ (∆ε) 195 (−4.36), 203 (−16.79), 252 (−1.56), 288 (−11.82) nm; ^1^H and ^13^C NMR data, see [Table 1](#marinedrugs-11-02230-t001){ref-type="table"}; HRESIMS *m/z* 275.1398 \[M + H\]^+^ (calcd for C~15~H~19~N~2~O~3~, 275.1390), 297.1216 \[M + Na\]^+^ (calcd for C~15~H~18~N~2~O~3~Na, 297.1215).

Compound **2**: white amorphous powder; \[α\]~D~^27^ −8.3 (*c* 0.12, CHCl~3~); UV (MeOH) λ~max~ (log ε) 215 (4.54), 237 (4.05), 331 (4.01) nm; ^1^H and ^13^C NMR data, see [Table 2](#marinedrugs-11-02230-t002){ref-type="table"}; HRESIMS *m/z* 211.0597 \[M + H\]^+^ (calcd for C~10~H~11~O~5~, 211.0607).

Compound **3**: white amorphous powder; UV (MeOH) λ~max~ (log ε) 200 (3.69), 217 (3.58), 255 (3.75), 288 (3.27), 300 (3.26), 333 (3.29) nm; ^1^H NMR data (at 500 MHz in DMSO-*d*~6~): δ~H~ 6.69 (s, H-3), 7.24 (s, H-5), 6.65 (s, H-9), 6.53 (s, H-11), 10.25 (s, OH-10), 2.73 (s, H-14), 3.89 (s, H-15), 3.94 (s, H-16); ^13^C NMR data (at 125 MHz in DMSO-*d*~6~): δ~C~ 102.0 (C, C-1), 163.5 (C, C-2), 97.3 (CH, C-3), 164.5 (C, C-4), 102.1 (CH, C-5), 139.8 (C, C-6), 116.6 (C, C-7), 137.7 (C, C-8), 116.6 (CH, C-9), 158.4 (C, C-10), 100.7 (CH, C-11), 153.5 (C, C-12), 156.1 (C, C-13), 24.8 (CH~3~, C-14), 56.1 (CH~3~, C-15), 55.6 (CH~3~, C-16). HRESIMS *m/z* 287.0918 \[M + H\]^+^ (calcd for C~16~H~15~O~5~, 287.0920).

3.5. Computational Details
--------------------------

Conformational searches for **1a** and **1b** were performed via the Dreiding force field in MarvinSketch regardless of rotations of methyl and hydroxyl groups \[[@B24-marinedrugs-11-02230]\], the geometries of which were further optimized at the B3LYP/6-31G (d) level in methanol to give the conformers (three for **1a** and two for **1b**, see [Figure 5](#marinedrugs-11-02230-f005){ref-type="fig"} and [Figure 6](#marinedrugs-11-02230-f006){ref-type="fig"}, respectively) within a 3 kcal/mol energy threshold from the global minimum without vibrational imaginary frequencies. The optimized conformers were then subjected to the calculations of ECD spectra using the time-dependent density functional theory (TD-DFT) method at the B3LYP/6-31G(d) level, which were drawn via SpecDic software with sigma = 0.25 and UV shift = −20 nm (magnified by 0.5 times) and weighted by Boltzmann distribution ([Figure 3](#marinedrugs-11-02230-f003){ref-type="fig"}), respectively \[[@B25-marinedrugs-11-02230]\]. All the above calculations were performed with the integral equation formalism variant polarizable continuum model (IEF-PCM) as implemented in Gaussian 09 \[[@B26-marinedrugs-11-02230]\].

![Conformers with populations of **1a** (in MeOH).](marinedrugs-11-02230-g005){#marinedrugs-11-02230-f005}

![Conformers with populations of **1b** (in MeOH).](marinedrugs-11-02230-g006){#marinedrugs-11-02230-f006}

3.6. Antibacterial Assays
-------------------------

The experiments were performed using the disk diffusion method \[[@B27-marinedrugs-11-02230]\]. Chloromycetin was used as positive control.

3.7. Brine Shrimp *(Artemia salina)* Lethality Assay
----------------------------------------------------

The assay was carried out following the literature \[[@B28-marinedrugs-11-02230]\]. Colchicine and DMSO were used as positive and negative controls, respectively.

4. Conclusions
==============

Two new compounds including pinodiketopiperazine A (**1**) and 6,7-dihydroxy-3-methoxy-3-methylphthalide (**2**), as well as two new naturally occurring compounds including alternariol 2,4-dimethyl ether (**3**) and [l]{.smallcaps}-5-oxoproline methyl ester (**4**), together with six known compounds (**5**--**10**) were isolated and identified from the marine sediment-derived fungus *Penicillium pinophilum* SD-272. The absolute configuration of compound **1** was determined by experimental and calculated ECD spectra. Compound **2** was found to possess potent lethality with LD~50~ 11.2 μM, while compounds **1**, **3**, and **5**--**8** displayed inhibitory activity against *Escherichia coli*, causing the 10.0, 9.0, 8.0, 8.0, 7.0, and 10.0 mm zones of inhibition, respectively.
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